Showing results (681-690 of 993) with videos related to

Sort By:
Pageof 100
British Journal of Cancer|December 1, 1995
Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell linesS Houlbrook, C M Addison, S L Davies, et al.
British Journal of Haematology|January 1, 1995
Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphomaS Kocialkowski, F Pezzella, H Morrison, et al.
Journal of the National Cancer Institute|July 16, 1997
Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patientsS B Fox, R D Leek, J Bliss, et al.
British Journal of Cancer|October 1, 1985
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patientsM Dowsett, A L Harris, R Stuart-Harris, et al.
The Journal of Pathology|February 1, 1997
Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancerA Giatromanolaki, M I Koukourakis, M Comley, et al.
Nucleic Acids Research|November 15, 1996
p53 regulates the minimal promoter of the human topoisomerase IIalpha geneM I Sandri, R J Isaacs, W M Ongkeko, et al.
Breast Cancer Research and Treatment|January 1, 1996
Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targetingA L Harris, H Zhang, A Moghaddam, et al.
British Journal of Cancer|September 15, 2001
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survivalA Giatromanolaki, M I Koukourakis, E Sivridis, et al.
European Journal of Clinical Investigation|September 22, 2007
Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancerA Giatromanolaki, M I Koukourakis, E Sivridis, et al.
British Journal of Cancer|November 1, 1996
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significanceL Kaklamanis, M I Koukourakis, R Leek, et al.
Pageof 100